Health Condition 1: K123- Oral mucositis (ulcerative)
Conditions
Interventions
Intervention1: Combined 660nm plus 810nm dual wavelength laser photobiomodulation: Diode laser (NovoLase Therapy pod, NovoLase Technologies, New Hampshire, USA), combined 660nm and 810nm wavelengths,
Sponsors
Srinivasaragahavan N
Eligibility
Inclusion criteria
Inclusion criteria: Children aged 3 to 15 years Oral mucositis WHO Grade 2 or greater secondary to cancer therapy Consenting parent and child willing to undergo laser photobiomodulation for 4 consecutive days and return for evaluation on day 7 post enrolment
Exclusion criteria
Exclusion criteria: Previous treatment with photobiomodulation for oral mucositis Presence of dysplastic oral lesions Reduction of mouth opening less than 1 cm Patients undergoing treatment with keratinocyte growth factor Parents and children who refuse the procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical grade of oral mucositis using WHO Oral Mucositis ScaleTimepoint: Baseline (day 0), day 1, day 2, day 3, day 4 and day 7 post enrolment | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain perception assessed by ChMIESTimepoint: Baseline (day 0), day 1, day 2, day 3, day 4 and day 7 post enrolment;Functional difficulty swallowing, eating, drinking assessed by ChMIESTimepoint: Baseline (day 0), day 1, day 2, day 3, day 4 and day 7 post enrolment;Analgesic use assessed by ChMIESTimepoint: Baseline (day 0), day 1, day 2, day 3, day 4 and day 7 post enrolment | — |
Countries
India
Contacts
Public ContactSRINIVASARAGAHAVAN N
bapuji dental college and hospital
Outcome results
None listed